维普中文期刊产品整合服务
21篇 您的检索式:作者名="RHOMBERG P R"
    题名 作者 年代 出处 被引量
1Persistence of Legionella pneumophila in a hospital's water system: a 13 -year survey显示文摘Rangel-Frausto MS Rhomberg P Hollis R J 1999Infect Control Hosp Epidemiol1999,20,:1
2Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program(USA)显示文摘Rhomberg P R Fritsche T R Sader H S 2006Diag Microbiol Infect Dis2006,56,1:1
3Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Inform at ion Collect ion Program (USA)显示文摘Rhomberg P R Fritsche T R Sader H S 0,,01:1
4Antimicrobial susceptibility pattern comparions among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program(USA) 显示文摘Rhomberg P R Fritsche T R Sader H S 2006Diag Microbiol Infect Dis2006,56,1:1
5Comparative spectrum and activity of NVP-PDF 386 (VRC4887), a new peptide deformylase inhibitor 显示文摘Jones R N Rhomberg P R 2003J Antimicrob Chemother2003,51,1:1
6A bipartite signal mediates the transfer of type Ⅳ secretion substrates of Bartonella henselae into human cells显示文摘Schulein R Guye P Rhomberg TA 2005PNAS2005,102,3:1
7Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004) 显示文摘Rhomberg P R Fritsche T R Sader H S 2006Diagn Microbiol lnfect Dis2006,,54:1
8Antimicrobialusage and resistatace trend relationships from the MYSTIC Programme in North America (1999-2001)显示文摘Mutnick A H Rhomberg P R Sader H S 2004J Antimicrob Chemother2004,53,2:1
9Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America ( 1999 - 2001 ) 显示文摘UTNICK A H RHOMBERG P R SADER H S 2004Antimicrob Chemother2004,53,2:1
10Antimicrobialactivity of CXA-101, a novel cephalosporin tested incombination with tazobactam against Enterobateriaceae,Pseudomonas aeruginosa having various resistancephenotypes 显示文摘Sader H S Rhomberg P R Farrell D J 2011Antimicrob Agents Chemother2011,55,5:1
11Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram - negative pathogens 显示文摘VAARA M SADER H S RHOMBERG P R 2013J Antimicrob Chemother2013,68,3:1
12Antimicrobial usage and resistatace trend relationships from the MYSTIC Programme in North America (1999- 2001)显示文摘Mutnick A H Rhomberg P R Sader H S et a1 2004J Antimicrob Chemother2004,53,2:1
13Tiamulin activity against fastidious and nonfastidious veterinary and human bacterial isolates:initial development of in vitro susceptibility test methods显示文摘Jone R N Pfaller M A Rhomberg P R 2002Journal of clinical Microbiology2002,40,2:1
14Summary trends for the meropenem yearly susceptibility test information collection program: a 10- year experience in the United State(1999 - 2008)显示文摘Rhomberg P R Jones R N 2009Diag Mi- crobiol Infect Dis2009,65,4:1
15Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999- 2005)显示文摘Deshpande L M Rhomberg P R Sader H S etal 2006Diagn Microbiol Infect Dis2006,56,4:1
16Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: Report from the MYSTIC Program (2002) in North America显示文摘Rhomberg P R Jones R N 2003Diagn Microbiol Infect Dis2003,47,1:1
17Antimicrobial usage and resistance trend relationships from theMYSTIC Programme in North America (1999-2001) 显示文摘MUTN1CK A H RHOMBERG P R SADER H S 2004JAntimicrob Chemoth2004,53,2:1
18Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999- 2005) 显示文摘Deshpande L M Rhomberg P R Sader H S 2006Diagn Microbiol Infect Dis2006,56,:1
19Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program in North America显示文摘RHOMBERG P R JONES R N MYSTIC STUDY GROUP 2003Diagn Microbiol Infect Dis2003,47,:1
20Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicicrobials: report from the MYSTIC Program (2002) in North America显示文摘Rhomberg P R Jones R N 2003Diagn Microbiol Infect Dis2003,47,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费